does physostigmine has direct nicotinic action in skeletal muscle

Yes, physostigmine is a reversible acetylcholinesterase inhibitor that has direct nicotinic action in skeletal muscle. By inhibiting the breakdown of acetylcholine, physostigmine increases the levels of this neurotransmitter at the neuromuscular junction, leading to increased muscle contraction and improved muscle strength. Physostigmine can be used medically to treat conditions such as myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue.